2015
DOI: 10.1038/ja.2015.123
|View full text |Cite
|
Sign up to set email alerts
|

Improved antibiotic production and silent gene activation in Streptomyces diastatochromogenes by ribosome engineering

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
30
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 26 publications
(36 citation statements)
references
References 18 publications
6
30
0
Order By: Relevance
“…The genetic characterization of rps12 (NCBI accession number: WP_016698050.1), rpl6 (NCBI accession number: WP_026419518.1) and 16S rDNA (NCBI accession number: CP025990; 1052752-1054270) from XC-11G revealed that no clear mutation site was located, which was consistent with previously reported cases [34][35][36][37]. Additionally, the genetic stability of XC-11G in CRM A biosynthesis was then validated by successive fermentation comparisons among three generations from XC-11G ( Fig.…”
Section: Activation Of Crm a Biosynthesis By Gene Expression-directedsupporting
confidence: 89%
“…The genetic characterization of rps12 (NCBI accession number: WP_016698050.1), rpl6 (NCBI accession number: WP_026419518.1) and 16S rDNA (NCBI accession number: CP025990; 1052752-1054270) from XC-11G revealed that no clear mutation site was located, which was consistent with previously reported cases [34][35][36][37]. Additionally, the genetic stability of XC-11G in CRM A biosynthesis was then validated by successive fermentation comparisons among three generations from XC-11G ( Fig.…”
Section: Activation Of Crm a Biosynthesis By Gene Expression-directedsupporting
confidence: 89%
“…Two endophytic Streptomycetes EA65 and EA67 were analyzed by LC-MS and they exhibited spectra for 15 bioactive compounds including antibacterial, antifungal, antiprotozoal and anthelmintic compounds. Strain EA65 showed close similarity at the 97% level to a rhizobacterium S. diastatochromogenes , a promising source of antifungal metabolites and novel natural antibiotics and used as biocontrol agents (Shentu et al, 2016 ). S. diastatochromogenes reportedly produces polyketomycin, momofulvenoneA, azdimycin, toyocamycin, concanamycin, and oligomycins.…”
Section: Discussionmentioning
confidence: 99%
“…The production of toyocamycin, tetramycin A, tetramycin P, and tetrin B were highest (4.1, 7.8, 5.1, and 12.9-fold, respectively) while using paromomycin to induce the mutation. Similarly, rsmG mutant strain of S. diastatochromogenes substantially increased the production of toyocamycin and also activated silent genes involved in the biosynthesis of secondary metabolites [37].…”
Section: Ribosome/rna Polymerase Engineering Approachmentioning
confidence: 96%